Hill Adam T, Pasteur Mark, Cornford Charles, Welham Sally, Bilton Diana
Department of Respiratory Medicine, Royal Infirmary and University of Edinburgh, Scotland, UK.
Prim Care Respir J. 2011 Jun;20(2):135-40. doi: 10.4104/pcrj.2011.00007.
The British Thoracic Society (BTS) has recently published a guideline for the management of non-cystic fibrosis (non-CF) bronchiectasis in children and adults. This paper summarises the key recommendations applicable to the primary care setting. The key points are: • Think of the diagnosis of bronchiectasis in adults and children who present with a chronic productive cough or unexplained haemoptysis, and in children with asthma which responds poorly to treatment; • High resolution computed tomography (HRCT) scanning is needed to confirm the diagnosis • Sputum culture should be obtained at the start of an exacerbation prior to initiating treatment with antibiotics; Treatment should be started whilst awaiting the sputum result and should be continued for 14 days; • Patients with bronchiectasis have significant morbidity. Management in primary care is aimed at improving morbidity, and includes; patient education, treatment and monitoring, as well as appropriate referral to secondary care including assessment for long term antibiotics.
英国胸科学会(BTS)最近发布了一份关于儿童和成人非囊性纤维化(非CF)支气管扩张症管理的指南。本文总结了适用于初级保健环境的关键建议。要点如下:•对于出现慢性咳痰或不明原因咯血的成人和儿童,以及对治疗反应不佳的哮喘儿童,应考虑支气管扩张症的诊断;•需要进行高分辨率计算机断层扫描(HRCT)以确诊;•在开始使用抗生素治疗之前,应在病情加重时采集痰培养样本;在等待痰检结果期间应开始治疗,并持续14天;•支气管扩张症患者有明显的发病率。初级保健中的管理旨在改善发病率,包括患者教育、治疗和监测,以及适当转诊至二级保健机构,包括评估长期使用抗生素的情况。